Compilation of all Scientific Publications

1.

Interactions between maternal killer cell immunoglobulin receptor genes and foetal HLA ligand genes contribute to type 1 diabetes susceptibility in Han Chinese.

Sun C, Sanjeevi S, Luo F, Zhi D, Sanjeevi CB.

Int J Immunogenet. 2016 Jun;43(3):125-30. doi: 10.1111/iji.12257. Epub 2016 Mar 17.

2.

Non-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies.

Maziarz M, Hagopian W, Palmer JP, Sanjeevi CB, Kockum I, Breslow N, Lernmark Å; Swedish Childhood Diabetes Register; Diabetes Incidence in Sweden Study Group; Type 1 Diabetes Genetics Consortium.

Genes Immun. 2015 Dec;16(8):541-51. doi: 10.1038/gene.2015.43. Epub 2015 Oct 29.

3.

Killer immunoglobulin receptor genes and their HLA-C ligand are associated with Type 1 diabetes in an Eastern Indian population.

Sanjeevi S, Sun C, Kanungo A, Sanjeevi CB.

Diabet Med. 2016 Jan;33(1):91-6. doi: 10.1111/dme.12815. Epub 2015 Jul 2.

4.

Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers.

Onengut-Gumuscu S, Chen WM, Burren O, Cooper NJ, Quinlan AR, Mychaleckyj JC, Farber E, Bonnie JK, Szpak M, Schofield E, Achuthan P, Guo H, Fortune MD, Stevens H, Walker NM, Ward LD, Kundaje A, Kellis M, Daly MJ, Barrett JC, Cooper JD, Deloukas P; Type 1 Diabetes Genetics Consortium, Todd JA, Wallace C, Concannon P, Rich SS.

Nat Genet. 2015 Apr;47(4):381-6. doi: 10.1038/ng.3245. Epub 2015 Mar 9.

5.

KIR genotyping in the selected population in Andhra Pradesh (India).

Vaishnav G, Krupanidhi S, Sanjeevi CB.

Roum Arch Microbiol Immunol. 2014 Jan-Jun;73(1-2):43-50.

6.

SNPs in the exons of Toll-like receptors are associated with susceptibility to type 1 diabetes in Chinese population.

Sun C, Zhi D, Shen S, Luo F, Sanjeevi CB.

Hum Immunol. 2014 Nov;75(11):1084-8. doi: 10.1016/j.humimm.2014.09.008. Epub 2014 Sep 26.

7.

CRYAB-650 C>G (rs2234702) affects susceptibility to Type 1 diabetes and IAA-positivity in Swedish population.

Sun C, Sedimbi SK, Ashok AK, Sanjeevi CB; Swedish Childhood Diabetes and the Diabetes Incidence in Sweden Study Groups.

Hum Immunol. 2012 Jul;73(7):759-66. doi: 10.1016/j.humimm.2012.04.004. Epub 2012 Apr 23.

8.

Rare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of European ancestry.

Hunt KA, Smyth DJ, Balschun T, Ban M, Mistry V, Ahmad T, Anand V, Barrett JC, Bhaw-Rosun L, Bockett NA, Brand OJ, Brouwer E, Concannon P, Cooper JD, Dias KR, van Diemen CC, Dubois PC, Edkins S, Fölster-Holst R, Fransen K, Glass DN, Heap GA, Hofmann S, Huizinga TW, Hunt S, Langford C, Lee J, Mansfield J, Marrosu MG, Mathew CG, Mein CA, Müller-Quernheim J, Nutland S, Onengut-Gumuscu S, Ouwehand W, Pearce K, Prescott NJ, Posthumus MD, Potter S, Rosati G, Sambrook J, Satsangi J, Schreiber S, Shtir C, Simmonds MJ, Sudman M, Thompson SD, Toes R, Trynka G, Vyse TJ, Walker NM, Weidinger S, Zhernakova A, Zoledziewska M; Type 1 Diabetes Genetics Consortium; UK Inflammatory Bowel Disease (IBD) Genetics Consortium; Wellcome Trust Case Control Consortium, Weersma RK, Gough SC, Sawcer S, Wijmenga C, Parkes M, Cucca F, Franke A, Deloukas P, Rich SS, Todd JA, van Heel DA.

Nat Genet. 2011 Dec 27;44(1):3-5. doi: 10.1038/ng.1037. No abstract available.

9.

Autoimmune diseases and risk of pulmonary embolism.

Sanjeevi CB.

Lancet. 2012 Jan 21;379(9812):200-1. doi: 10.1016/S0140-6736(11)61510-9. Epub 2011 Nov 25. No abstract available.

10.

Killer cell immunoglobulin-like receptor along with HLA-C ligand genes are associated with type 1 diabetes in Chinese Han population.

Zhi D, Sun C, Sedimbi SK, Luo F, Shen S, Sanjeevi CB.

Diabetes Metab Res Rev. 2011 Nov;27(8):872-7. doi: 10.1002/dmrr.1264.

11.

HLA class II alleles and haplotypes in Lithuanian children with type 1 diabetes and healthy children (HLA and type 1 diabetes).

Skrodenienė E, Marčiulionytė D, Padaiga Z, Jašinskienė E, Sadauskaitė-Kuehne V, Sanjeevi CB, Ludvigsson J.

Medicina (Kaunas). 2010;46(8):505-10.

12.

Prospective study of human papillomavirus (HPV) types, HPV persistence, and risk of squamous cell carcinoma of the cervix.

Sundström K, Eloranta S, Sparén P, Arnheim Dahlström L, Gunnell A, Lindgren A, Palmgren J, Ploner A, Sanjeevi CB, Melbye M, Dillner J, Adami HO, Ylitalo N.

Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2469-78. doi: 10.1158/1055-9965.EPI-10-0424. Epub 2010 Jul 29.

13.

Designing and implementing sample and data collection for an international genetics study: the Type 1 Diabetes Genetics Consortium (T1DGC).

Hilner JE, Perdue LH, Sides EG, Pierce JJ, Wägner AM, Aldrich A, Loth A, Albret L, Wagenknecht LE, Nierras C, Akolkar B; T1DGC.

Clin Trials. 2010;7(1 Suppl):S5-S32. doi: 10.1177/1740774510373497. Epub 2010 Jul 5.

14.

Prospective study of human papillomavirus and risk of cervical adenocarcinoma.

Dahlström LA, Ylitalo N, Sundström K, Palmgren J, Ploner A, Eloranta S, Sanjeevi CB, Andersson S, Rohan T, Dillner J, Adami HO, Sparén P.

Int J Cancer. 2010 Oct 15;127(8):1923-30. doi: 10.1002/ijc.25408.

15.

The association between the PTPN22 1858C>T variant and type 1 diabetes depends on HLA risk and GAD65 autoantibodies.

Maziarz M, Janer M, Roach JC, Hagopian W, Palmer JP, Deutsch K, Sanjeevi CB, Kockum I, Breslow N, Lernmark A; Swedish Childhood Diabetes Register; Diabetes Incidence in Sweden Study Group.

Genes Immun. 2010 Jul;11(5):406-15. doi: 10.1038/gene.2010.12. Epub 2010 May 6.

16.

[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].

Tan YY, Lin J, Huang G, Tang WL, Sedimbi SK, Sanjeevi CB, Zhou ZG.

Zhonghua Yi Xue Za Zhi. 2010 Jan 26;90(4):236-40. Chinese.

17.

Prevention of beta-cell destruction in autoimmune diabetes: current approaches and future prospects.

Sedimbi SK, Sanjeevi CB.

Adv Exp Med Biol. 2010;654:611-26. doi: 10.1007/978-90-481-3271-3_26. Review.

18.

Type 1 diabetes research: Newer approaches and exciting developments.

Sanjeevi CB.

Int J Diabetes Dev Ctries. 2009 Apr;29(2):49-51. doi: 10.4103/0973-3930.53119. No abstract available.

19.

Alternative routes of insulin delivery.

Krishnankutty RK, Mathew A, Sedimbi SK, Suryanarayan S, Sanjeevi CB.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009 Oct;34(10):933-48. Review.

20.

Diabetes--role of epigenetics, genetics, and physiological factors.

Krupanidhi S, Sedimbi SK, Vaishnav G, Madhukar SS, Sanjeevi CB.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009 Sep;34(9):837-45. Review.

21.

Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes.

Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA, Julier C, Morahan G, Nerup J, Nierras C, Plagnol V, Pociot F, Schuilenburg H, Smyth DJ, Stevens H, Todd JA, Walker NM, Rich SS; Type 1 Diabetes Genetics Consortium.

Nat Genet. 2009 Jun;41(6):703-7. doi: 10.1038/ng.381. Epub 2009 May 10.

22.

Epigenetics and epigenetic mechanisms in disease with emphasis on autoimmune diseases.

Krupanidhi S, Sedimbi SK, Sanjeevi CB.

J Assoc Physicians India. 2008 Nov;56:875-80. Review.

23.

Type 1 diabetes versus type 2 diabetes with onset in persons younger than 20 years of age.

Unnikrishnan AG, Bhatia E, Bhatia V, Bhadada SK, Sahay RK, Kannan A, Kumaravel V, Sarma D, Ganapathy B, Thomas N, John M, Jayakumar RV, Kumar H, Nair V, Sanjeevi CB.

Ann N Y Acad Sci. 2008 Dec;1150:239-44. doi: 10.1196/annals.1447.056.

24.

Variations in incidence of type 1 diabetes in different municipalities of stockholm.

Gopinath S, Ortqvist E, Norgren S, Green A, Sanjeevi CB.

Ann N Y Acad Sci. 2008 Dec;1150:200-7. doi: 10.1196/annals.1447.057.

25.

Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.

Shastry A, Sedimbi SK, Rajalingam R, Rumba I, Kanungo A, Sanjeevi CB.

Ann N Y Acad Sci. 2008 Dec;1150:133-8. doi: 10.1196/annals.1447.058.

26.

Risk conferred by HLA-DR and DQ for type 1 diabetes in 0-35-year age group in Sweden.

Sanjeevi CB, Sedimbi SK, Landin-Olsson M, Kockum I, Lernmark A; Swedish Childhood Diabetes and the Diabetes Incidence in Sweden Study Groups.

Ann N Y Acad Sci. 2008 Dec;1150:106-11. doi: 10.1196/annals.1447.061.

27.

The IDS conducts standardization of assays for the measurement of autoantibodies and of T cells in autoimmune diabetes. Preface.

Sanjeevi CB, Schatz DA, Atkinson MA.

Ann N Y Acad Sci. 2008 Dec;1150:xiii. doi: 10.1196/annals.1447.066. No abstract available.

28.

Copper & biological health.

Krupanidhi S, Sreekumar A, Sanjeevi CB.

Indian J Med Res. 2008 Oct;128(4):448-61. Review.

29.

Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.

Shastry A, Sedimbi SK, Rajalingam R, Nikitina-Zake L, Rumba I, Wigzell H, Sanjeevi CB.

Int J Immunogenet. 2008 Dec;35(6):439-46. doi: 10.1111/j.1744-313X.2008.00804.x.

30.

Omega-3 fatty acids for nutrition and medicine: considering microalgae oil as a vegetarian source of EPA and DHA.

Doughman SD, Krupanidhi S, Sanjeevi CB.

Curr Diabetes Rev. 2007 Aug;3(3):198-203. Review.

31.

IA-2 autoantibodies in incident type I diabetes patients are associated with a polyadenylation signal polymorphism in GIMAP5.

Shin JH, Janer M, McNeney B, Blay S, Deutsch K, Sanjeevi CB, Kockum I, Lernmark A, Graham J; Swedish Childhood Diabetes Study Group; Diabetes Incidence in Sweden Study Group, Arnqvist H, Björck E, Eriksson J, Nyström L, Ohlson LO, Scherstén B, Ostman J, Aili M, Bååth LE, Carlsson E, Edenwall H, Forsander G, Granström BW, Gustavsson I, Hanås R, Hellenberg L, Hellgren H, Holmberg E, Hörnell H, Ivarsson SA, Johansson C, Jonsell G, Kockum K, Lindblad B, Lindh A, Ludvigsson J, Myrdal U, Neiderud J, Segnestam K, Sjöblad S, Skogsberg L, Strömberg L, Ståhle U, Thalme B, Tullus K, Tuvemo T, Wallensteen M, Westphal O, Aman J.

Genes Immun. 2007 Sep;8(6):503-12. Epub 2007 Jul 19.

32.

Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis.

Thomson G, Valdes AM, Noble JA, Kockum I, Grote MN, Najman J, Erlich HA, Cucca F, Pugliese A, Steenkiste A, Dorman JS, Caillat-Zucman S, Hermann R, Ilonen J, Lambert AP, Bingley PJ, Gillespie KM, Lernmark A, Sanjeevi CB, Rønningen KS, Undlien DE, Thorsby E, Petrone A, Buzzetti R, Koeleman BP, Roep BO, Saruhan-Direskeneli G, Uyar FA, Günoz H, Gorodezky C, Alaez C, Boehm BO, Mlynarski W, Ikegami H, Berrino M, Fasano ME, Dametto E, Israel S, Brautbar C, Santiago-Cortes A, Frazer de Llado T, She JX, Bugawan TL, Rotter JI, Raffel L, Zeidler A, Leyva-Cobian F, Hawkins BR, Chan SH, Castano L, Pociot F, Nerup J.

Tissue Antigens. 2007 Aug;70(2):110-27.

33.

SUMO4 M55V polymorphism affects susceptibility to type I diabetes in HLA DR3- and DR4-positive Swedish patients.

Sedimbi SK, Luo XR, Sanjeevi CB; Swedish Childhood Diabetes Study Group; Diabetes Incidence in Sweden Study Group, Lernmark A, Landin-Olsson M, Arnqvist H, Björck E, Nyström L, Ohlson LO, Scherstén B, Ostman J, Aili M, Bååth LE, Carlsson E, Edenwall H, Forsander G, Granström BW, Gustavsson I, Hanås R, Hellenberg L, Hellgren H, Holmberg E, Hörnell H, Ivarsson SA, Johansson C, Jonsell G, Kockum K, Lindblad B, Lindh A, Ludvigsson J, Myrdal U, Neiderud J, Segnestam K, Sjöblad S, Skogsberg L, Strömberg L, Ståhle U, Thalme B, Tullus K, Tuvemo T, Wallensteen M, Westphal O, Dahlquist G, Aman J.

Genes Immun. 2007 Sep;8(6):518-21. Epub 2007 Jun 7.

34.

No association of SUMO4 M55V with autoimmune diabetes in Asian-Indian patients.

Sedimbi SK, Kanungo A, Shastry A, Park Y, Sanjeevi CB.

Int J Immunogenet. 2007 Apr;34(2):137-42.

35.

MICA marks additional risk factors for Type 1 diabetes on extended HLA haplotypes: an association and meta-analysis.

Alizadeh BZ, Eerligh P, van der Slik AR, Shastry A, Zhernakova A, Valdigem G, Bruining JG, Sanjeevi CB, Wijmenga C, Roep BO, Koeleman BP.

Mol Immunol. 2007 Apr;44(11):2806-12. Epub 2007 Mar 12.

36.

Association of SUMO4 M55V polymorphism with autoimmune diabetes in Latvian patients.

Sedimbi SK, Shastry A, Park Y, Rumba I, Sanjeevi CB.

Ann N Y Acad Sci. 2006 Oct;1079:273-7.

37.

Predominance of the group A killer Ig-like receptor haplotypes in Korean patients with T1D.

Park Y, Choi H, Park H, Park S, Yoo EK, Kim D, Sanjeevi CB.

Ann N Y Acad Sci. 2006 Oct;1079:240-50.

38.

MHC class I chain-related gene-A is associated with IA2 and IAA but not GAD in Swedish type 1 diabetes mellitus.

Gupta M, Graham J, McNeeny B, Zarghami M, Landin-Olsson M, Hagopian WA, Palmer J, Lernmark A, Sanjeevi CB.

Ann N Y Acad Sci. 2006 Oct;1079:229-39.

39.

TSH receptor antibodies in subjects with type 1 diabetes mellitus.

Unnikrishnan AG, Kumaravel V, Nair V, Rao A, Jayakumar RV, Kumar H, Sanjeevi CB.

Ann N Y Acad Sci. 2006 Oct;1079:220-5.

41.

Polymorphisms of TNF microsatellite marker a and HLA-DR-DQ in diabetes mellitus-a study in 609 Swedish subjects.

Törn C, Hillman M, Sanjeevi CB, Landin-Olsson M.

Hum Immunol. 2006 Jul;67(7):527-34. Epub 2006 May 9.

42.

Gestational diabetes mellitus in India.

Seshiah V, Balaji V, Balaji MS, Sanjeevi CB, Green A.

J Assoc Physicians India. 2004 Sep;52:707-11.

43.

A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia.

Arnheim L, Dillner J, Sanjeevi CB.

Tissue Antigens. 2005 Mar;65(3):252-9.

44.

Killer cell immunoglobulin-like receptor genes in Latvian patients with type 1 diabetes mellitus and healthy controls.

Nikitina-Zake L, Rajalingham R, Rumba I, Sanjeevi CB.

Ann N Y Acad Sci. 2004 Dec;1037:161-9.

45.

MICA gene polymorphism in HBDI multiplex families.

Nikitina-Zake L, Ghaderi M, Park Y, Babu S, Eisenbarth G, Sanjeevi CB.

Ann N Y Acad Sci. 2004 Dec;1037:150-6.

46.
47.

Prevalence of GAD65 antibodies in lean subjects with type 2 diabetes.

Unnikrishnan AG, Singh SK, Sanjeevi CB.

Ann N Y Acad Sci. 2004 Dec;1037:118-21.

48.

Different HLA-DR-DQ and MHC class I chain-related gene A (MICA) genotypes in autoimmune and nonautoimmune gestational diabetes in a Swedish population.

Törn C, Gupta M, Sanjeevi CB, Aberg A, Frid A, Landin-Olsson M.

Hum Immunol. 2004 Dec;65(12):1443-50.

49.

Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus.

Gambelunghe G, Gerli R, Bocci EB, Del Sindaco P, Ghaderi M, Sanjeevi CB, Bistoni O, Bini V, Falorni A.

Rheumatology (Oxford). 2005 Mar;44(3):287-92. Epub 2004 Nov 2. Erratum in: Rheumatology (Oxford). 2005 Apr;44(4):569.

50.

No evidence for autoimmunity as a major cause of the empty sella syndrome.

Bensing S, Rorsman F, Crock P, Sanjeevi C, Ericson K, Kämpe O, Brismar K, Hulting AL.

Exp Clin Endocrinol Diabetes. 2004 May;112(5):231-5.

51.

Lack of association of human chemokine receptor gene polymorphisms CCR2-64I and CCR5-Delta32 with autoimmune Addison's disease.

Gambelunghe G, Ghaderi M, Gharizadeh B, Brozzetti A, Tortoioli C, Del Sindaco P, Sanjeevi CB, Hjelmström P, Sirsjö A, Nyren P, Santeusanio F, Falorni A.

Eur J Immunogenet. 2004 Apr;31(2):73-6.

52.

Association of the proinflammatory haplotype (MICA5.1/TNF2/TNFa2/DRB1*03) with polymyositis and dermatomyositis.

Hassan AB, Nikitina-Zake L, Sanjeevi CB, Lundberg IE, Padyukov L.

Arthritis Rheum. 2004 Mar;50(3):1013-5. No abstract available.

55.

Frequency of latent autoimmune diabetes in adults in Asian patients diagnosed as type 2 diabetes in Birmingham, United Kingdom.

Tica V, Hanif MW, Andersson A, Valsamakis G, Barnett AH, Kumar S, Sanjeevi CB.

Ann N Y Acad Sci. 2003 Nov;1005:356-8.

56.

MIC-A genotypes 4/5.1 and 9/9 are positively associated with type 1 diabetes mellitus in Brazilian population.

Tica V, Nikitina-Zake L, Donadi E, Sanjeevi CB.

Ann N Y Acad Sci. 2003 Nov;1005:310-3.

57.

Inheritance of MHC class II genes in Lithuanian families with type 1 diabetes.

Sadauskaite-Kuehne V, Veys K, Ludvigsson J, Padaiga Z, Sanjeevi CB.

Ann N Y Acad Sci. 2003 Nov;1005:295-300.

58.

Heterozygosity for MICA5.0/MICA5.1 and HLA-DR3-DQ2/DR4-DQ8 are independent genetic risk factors for latent autoimmune diabetes in adults.

Törn C, Gupta M, Nikitina Zake L, Sanjeevi CB, Landin-Olsson M.

Hum Immunol. 2003 Sep;64(9):902-9.

59.

Coxsackie virus B antibodies are increased in HLA DR3-MICA5.1 positive type 1 diabetes patients in the Linköping region of Sweden.

Gupta M, Nikitina-Zake L, Landin-Olsson M, Kockum I, Sanjeevi CB.

Hum Immunol. 2003 Sep;64(9):874-9.

60.

Lack of association of CCR2-64I and CCR5-Delta 32 with type 1 diabetes and latent autoimmune diabetes in adults.

Gambelunghe G, Ghaderi M, Brozzetti A, Del Sindaco P, Gharizadeh B, Nyren P, Hjelmström P, Nikitina-Zake L, Sanjeevi CB, Falorni A; Umbria Type 1 Diabetes Registry.

Hum Immunol. 2003 Jun;64(6):629-32.

61.

Association between the transmembrane region polymorphism of MHC class I chain related gene-A and type 1 diabetes mellitus in Sweden.

Gupta M, Nikitina-Zake L, Zarghami M, Landin-Olsson M, Kockum I, Lernmark A, Sanjeevi CB.

Hum Immunol. 2003 May;64(5):553-61.

62.

MICA4/HLA-DRB1*04/TNF1 haplotype is associated with mixed connective tissue disease in Swedish patients.

Hassan AB, Nikitina-Zake L, Padyukov L, Karlsson G, Gupta M, Lundberg IE, Sanjeevi CB.

Hum Immunol. 2003 Feb;64(2):290-6.

63.

Additional association of intra-MHC genes, MICA and D6S273, with Addison's disease.

Park YS, Sanjeevi CB, Robles D, Yu L, Rewers M, Gottlieb PA, Fain P, Eisenbarth GS.

Tissue Antigens. 2002 Aug;60(2):155-63.

64.

Risk of invasive cervical cancer associated with polymorphic HLA DR/DQ haplotypes.

Ghaderi M, Wallin KL, Wiklund F, Zake LN, Hallmans G, Lenner P, Dillner J, Sanjeevi CB.

Int J Cancer. 2002 Aug 20;100(6):698-701.

65.

Genetic analysis of multicase families of visceral leishmaniasis in northeastern Brazil: no major role for class II or class III regions of HLA.

Peacock CS, Sanjeevi CB, Shaw MA, Collins A, Campbell RD, March R, Silveira F, Costa J, Coste CH, Nascimento MD, Siddiqui R, Shaw JJ, Blackwell JM.

Genes Immun. 2002 Sep;3(6):350-8.

Class II MHC alleles in rheumatoid arthritis in Tamilnadu, India: is there an association?

Parthiban M, Madhavan R, Porkodi R, Rajendran CP, Zake L, Sanjeevi CB, Chandrasekaran AN.

Ann N Y Acad Sci. 2002 Apr;958:412-5.

67.

HLA class I and class II association with ankylosing spondylitis in a southern Indian population.

Madhavan R, Parthiban M, Rajendran CP, Chandrasekaran AN, Zake L, Sanjeevi CB.

Ann N Y Acad Sci. 2002 Apr;958:403-7.

69.

Tumor necrosis factor-alpha allele 2 shows an association with insulin-dependent diabetes mellitus in Latvians.

Shtauvere-Brameus A, Dabadghao P, Rumba I, Sanjeevi CB.

Ann N Y Acad Sci. 2002 Apr;958:357-61.

70.

Microsatellite allele A5.1 of MHC class I chain-related gene A is associated with latent autoimmune diabetes in adults in Latvia.

Berzina L, Shtauvere-Brameus A, Rumba I, Sanjeevi CB.

Ann N Y Acad Sci. 2002 Apr;958:353-6.

71.

Microsatellite allele 5 of MHC class I chain-related gene a increases the risk for insulin-dependent diabetes mellitus in latvians.

Shtauvere-Brameus A, Ghaderi M, Rumba I, Sanjeevi CB.

Ann N Y Acad Sci. 2002 Apr;958:349-52.

72.

DR3 is associated with type 1 diabetes and blood group ABO incompatibility.

Berzina L, Ludvigsson J, Sadauskaite-Kuehne V, Nelson N, Shtauvere-Brameus A, Sanjeevi CB.

Ann N Y Acad Sci. 2002 Apr;958:345-8.

74.

ICA12 autoantibodies are associated with non-DR3/non-DR4 in patients with latent autoimmune diabetes in adults from northern India.

Gupta M, Tandon N, Shtauvere-Brameus A, Sanjeevi CB.

Ann N Y Acad Sci. 2002 Apr;958:329-32.

75.

Molecular modeling of eluted peptides from DQ6 molecules (DQB1*0602 and DQB1*0604) negatively and positively associated with type 1 diabetes.

Sanjeevi CB, Lybrand TP, Stevanovic S, Rammensee HG.

Ann N Y Acad Sci. 2002 Apr;958:317-20.

76.

Newborn screening for high-risk human leukocyte antigen markers associated with insulin-dependent diabetes mellitus: the ABIS study.

Berzina L, Shtauvere-Brameus A, Ludvigsson J, Sanjeevi CB.

Ann N Y Acad Sci. 2002 Apr;958:312-6.

77.

MHC class I chain-related gene alleles 5 and 5.1 are transmitted more frequently to type 1 diabetes offspring in HBDI families.

Zake LN, Ghaderi M, Park YS, Babu S, Eisenbarth G, Sanjeevi CB.

Ann N Y Acad Sci. 2002 Apr;958:309-11.

78.

Antibodies to new beta cell antigen ICA12 in Latvian diabetes patients.

Shtauvere-Brameus A, Hagopian W, Rumba I, Sanjeevi CB.

Ann N Y Acad Sci. 2002 Apr;958:297-304.

79.

BCG vaccination and GAD65 and IA-2 autoantibodies in autoimmune diabetes in southern India.

Sanjeevi CB, Das AK, Shtauvere-Brameus A.

Ann N Y Acad Sci. 2002 Apr;958:293-6.

80.

Autoimmune diabetes in 26 villages outside Madras.

Datta M, Shtauvere-Brameus A, Gupta V, Mani MK, Sanjeevi CB.

Ann N Y Acad Sci. 2002 Apr;958:285-8.

81.

Women diagnosed with gestational diabetes mellitus do not carry antibodies against minor islet cell antigens.

Balaji M, Shtauvere-Brameus A, Balaji V, Seshiah V, Sanjeevi CB.

Ann N Y Acad Sci. 2002 Apr;958:281-4.

82.
83.

GAD65 and ICA512 antibodies in undernourished and normally nourished south Indian patients with diabetes.

Das AK, Shtauvere-Brameus A, Sanjeevi CB.

Ann N Y Acad Sci. 2002 Apr;958:247-50.

85.

Increased autoantibodies to SOX13 in Swedish patients with type 1 diabetes.

Törn C, Shtauvere-Brameus A, Sanjeevi CB, Landin-Olsson M.

Ann N Y Acad Sci. 2002 Apr;958:218-23.

86.

Prevalence of ICA-12 and other autoantibodies in north Indian patients with early-onset diabetes.

Tandon N, Shtauvere-Brameus A, Hagopian WA, Sanjeevi CB.

Ann N Y Acad Sci. 2002 Apr;958:214-7.

87.

Immunogenetic studies on malnutrition-modulated diabetes mellitus.

Sanjeevi CB, Kanungo A, Samal KC.

Ann N Y Acad Sci. 2002 Apr;958:144-7.

88.

Molecular mechanisms involved in the etiopathogenesis of malnutrition-modulated diabetes mellitus.

Kanungo A, Samal KC, Sanjeevi CB.

Ann N Y Acad Sci. 2002 Apr;958:138-43.

89.

Clinicoepidemiological and biochemical profile of malnutrition-modulated diabetes mellitus.

Samal KC, Kanungo A, Sanjeevi CB.

Ann N Y Acad Sci. 2002 Apr;958:131-7.

90.

Genetics of latent autoimmune diabetes in adults.

Sanjeevi CB, Gambelunghe G, Falorni A, Shtauvere-Brameus A, Kanungo A.

Ann N Y Acad Sci. 2002 Apr;958:107-11.

91.

Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes.

Graham J, Hagopian WA, Kockum I, Li LS, Sanjeevi CB, Lowe RM, Schaefer JB, Zarghami M, Day HL, Landin-Olsson M, Palmer JP, Janer-Villanueva M, Hood L, Sundkvist G, Lernmark A, Breslow N, Dahlquist G, Blohmé G; Diabetes Incidence in Sweden Study Group; Swedish Childhood Diabetes Study Group.

Diabetes. 2002 May;51(5):1346-55.

93.

Atopy in children in relation to BCG vaccination and genetic polymorphisms at SLC11A1 (formerly NRAMP1) and D2S1471.

Alm JS, Sanjeevi CB, Miller EN, Dabadghao P, Lilja G, Pershagen G, Blackwell JM, Scheynius A.

Genes Immun. 2002 Apr;3(2):71-7.

94.

Tumor necrosis factor A and MHC class I chain related gene A (MIC-A) polymorphisms in Swedish patients with cervical cancer.

Ghaderi M, Nikitina Zake L, Wallin K, Wiklund F, Hallmans G, Lenner P, Dillner J, Sanjeevi CB.

Hum Immunol. 2001 Oct;62(10):1153-8.

95.

One hundred years of Nobel Prize and diabetes.

Sanjeevi CB.

Diabetologia. 2001 Sep;44(9):37-8. No abstract available.

96.

Two distinct MICA gene markers discriminate major autoimmune diabetes types.

Gambelunghe G, Ghaderi M, Tortoioli C, Falorni A, Santeusanio F, Brunetti P, Sanjeevi CB, Falorni A; Umbria Type 1 Diabetes Registry.

J Clin Endocrinol Metab. 2001 Aug;86(8):3754-60.

98.

MICA polymorphism is associated with type 1 diabetes in the Korean population.

Park Y, Lee H, Sanjeevi CB, Eisenbarth GS.

Diabetes Care. 2001 Jan;24(1):33-8.

99.

Tumor necrosis factor a-11 and DR15-DQ6 (B*0602) haplotype increase the risk for cervical intraepithelial neoplasia in human papillomavirus 16 seropositive women in Northern Sweden.

Ghaderi M, Nikitina L, Peacock CS, Hjelmström P, Hallmans G, Wiklund F, Lenner P, Blackwell JM, Dillner J, Sanjeevi CB.

Cancer Epidemiol Biomarkers Prev. 2000 Oct;9(10):1067-70.

100.

Polymorphism at NRAMP1 and D2S1471 loci associated with juvenile rheumatoid arthritis.

Sanjeevi CB, Miller EN, Dabadghao P, Rumba I, Shtauvere A, Denisova A, Clayton D, Blackwell JM.

Arthritis Rheum. 2000 Jun;43(6):1397-404.

101.

Association of MHC Class I chain-related A (MIC-A) gene polymorphism with Type I diabetes.

Gambelunghe G, Ghaderi M, Cosentino A, Falorni A, Brunetti P, Falorni A, Sanjeevi CB.

Diabetologia. 2000 Apr;43(4):507-14.

102.

Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies.

Gambelunghe G, Forini F, Laureti S, Murdolo G, Toraldo G, Santeusanio F, Brunetti P, Sanjeevi CB, Falorni A.

Clin Endocrinol (Oxf). 2000 May;52(5):565-73.

103.

HLA-DQ6-mediated protection in IDDM.

Sanjeevi CB.

Hum Immunol. 2000 Feb;61(2):148-53. Review.

104.

Complex interaction between HLA DR and DQ in conferring risk for childhood type 1 diabetes.

Kockum I, Sanjeevi CB, Eastman S, Landin-Olsson M, Dahlquist G, Lernmark A.

Eur J Immunogenet. 1999 Oct;26(5):361-72.

105.

MICA gene polymorphism and the risk to develop cervical intraepithelial neoplasia.

Ghaderi M, Hjelmström P, Hallmans G, Wiklund F, Lenner P, Dillner J, Sanjeevi CB.

Hum Immunol. 1999 Oct;60(10):970-3.

106.

Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease.

Gambelunghe G, Falorni A, Ghaderi M, Laureti S, Tortoioli C, Santeusanio F, Brunetti P, Sanjeevi CB.

J Clin Endocrinol Metab. 1999 Oct;84(10):3701-7.

108.

Negative association between type 1 diabetes and HLA DQB1*0602-DQA1*0102 is attenuated with age at onset. Swedish Childhood Diabetes Study Group.

Graham J, Kockum I, Sanjeevi CB, Landin-Olsson M, Nyström L, Sundkvist G, Arnqvist H, Blohmé G, Lithner F, Littorin B, Scherstén B, Wibell L, Ostman J, Lernmark A, Breslow N, Dahlquist G.

Eur J Immunogenet. 1999 Apr-Jun;26(2-3):117-27.

109.

HLA-DR and -DQ gene polymorphism in Latvian patients with insulin-dependent diabetes mellitus.

Shtauvere A, Rumba I, Dzivite I, Sanjeevi CB.

Tissue Antigens. 1998 Oct;52(4):385-8.

110.

T-cell expansions with conserved T-cell receptor beta chain motifs in the peripheral blood of HLA-DRB1*0401 positive patients with necrotizing vasculitis.

Grunewald J, Halapi E, Wahlström J, Giscombe R, Nityanand S, Sanjeevi C, Lefvert AK.

Blood. 1998 Nov 15;92(10):3737-44.

111.

Polymorphism in tumor necrosis factor genes associated with myasthenia gravis.

Hjelmström P, Peacock CS, Giscombe R, Pirskanen R, Lefvert AK, Blackwell JM, Sanjeevi CB.

J Neuroimmunol. 1998 Aug 1;88(1-2):137-43.

112.

Myasthenia gravis with thymic hyperplasia is associated with polymorphisms in the tumor necrosis factor region.

Hjelmström P, Peacock CS, Giscombe R, Pirskanen R, Lefvert AK, Blackwell JM, Sanjeevi CB.

Ann N Y Acad Sci. 1998 May 13;841:368-70. No abstract available.

113.

Structural differences between HLA-DQ molecules associated with myasthenia gravis characterized by molecular modeling.

Hjelmström P, DeWeese-Scott C, Penzotti JE, Lybrand TP, Sanjeevi CB.

J Neuroimmunol. 1998 May 1;85(1):102-5.

114.
115.

Analysis of critical residues of HLA-DQ6 molecules in insulin-dependent diabetes mellitus.

Sanjeevi CB, DeWeese C, Landin-Olsson M, Kockum I, Dahlquist G, Lernmark A, Lybrand TP.

Tissue Antigens. 1997 Jul;50(1):61-5.

116.

HLA-DQ associations and T-cell receptor V-gene usage in peripheral blood of Swedish myasthenia gravis patients.

Hjelmström P, Giscombe R, Lefvert AK, Grünewald J, Pirskanen R, Sanjeevi CB.

Eur J Immunogenet. 1997 Jun;24(3):179-89.

117.

TAP polymorphisms in Swedish myasthenia gravis patients.

Hjelmström P, Giscombe R, Lefvert AK, Pirskanen R, Kockum I, Landin-Olsson M, Sanjeevi CB.

Tissue Antigens. 1997 Feb;49(2):176-9.

118.

A bias in the alphabeta T cell receptor variable region gene usage in Takayasu's arteritis.

Nityanand S, Giscombe R, Srivastava S, Hjelmström P, Sanjeevi CB, Sinha N, Grunewald J, Lefvert AK.

Clin Exp Immunol. 1997 Feb;107(2):261-8.

119.

HLA class II genes in Latvian patients with juvenile rheumatoid arthritis.

Rumba I, Denisova A, Sochnev A, Nilsson B, Sanjeevi CB.

Tissue Antigens. 1997 Jan;49(1):56-60.

120.

Different HLA-DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish women.

Sanjeevi CB, Hjelmström P, Hallmans G, Wiklund F, Lenner P, Angström T, Dillner J, Lernmark A.

Int J Cancer. 1996 Nov 15;68(4):409-14.

121.

Genetic and immunological findings in patients with newly diagnosed insulin-dependent diabetes mellitus. The Swedish Childhood Diabetes Study Group and The Diabetes Incidence in Sweden Study (DISS) Group.

Kockum I, Lernmark A, Dahlquist G, Falorni A, Hagopian WA, Landin-Olsson M, Li LC, Luthman H, Palmer JP, Sanjeevi CB, Sundkvist G, Ostman IJ.

Horm Metab Res. 1996 Jul;28(7):344-7.

122.

Polymorphic amino acid domains of the HLA-DQ molecule are associated with disease heterogeneity in myasthenia gravis.

Hjelmström P, Giscombe R, Lefvert AK, Pirskanen R, Kockum I, Landin-Olsson M, Sanjeevi CB.

J Neuroimmunol. 1996 Apr;65(2):125-31.

123.

DR4 subtypes and their molecular properties in a population-based study of Swedish childhood diabetes.

Sanjeevi CB, Höök P, Landin-Olsson M, Kockum I, Dahlquist G, Lybrand TP, Lernmark A.

Tissue Antigens. 1996 Apr;47(4):275-83.

124.

HLA and glutamic acid decarboxylase in human insulin-dependent diabetes mellitus.

Sanjeevi CB, Falorni A, Kockum I, Hagopian WA, Lernmark A.

Diabet Med. 1996 Mar;13(3):209-17. Review.

125.

Population analysis of protection by HLA-DR and DQ genes from insulin-dependent diabetes mellitus in Swedish children with insulin-dependent diabetes and controls.

Kockum I, Sanjeevi CB, Eastman S, Landin-Olsson M, Dahlquist G, Lernmark A.

Eur J Immunogenet. 1995 Dec;22(6):443-65.

126.

Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children.

Hagopian WA, Sanjeevi CB, Kockum I, Landin-Olsson M, Karlsen AE, Sundkvist G, Dahlquist G, Palmer J, Lernmark A.

J Clin Invest. 1995 Apr;95(4):1505-11.

127.

Effects of the second HLA-DQ haplotype on the association with childhood insulin-dependent diabetes mellitus.

Sanjeevi CB, Landin-Olsson M, Kockum I, Dahlquist G, Lernmark A.

Tissue Antigens. 1995 Feb;45(2):148-52.

128.

Different HLA-DQ are positively and negatively associated in Swedish patients with myasthenia gravis.

Hjelmström P, Giscombe R, Lefvert AK, Pirskanen R, Kockum I, Landin-Olsson M, Sanjeevi CB.

Autoimmunity. 1995;22(1):59-65.

129.

Polymorphic amino acid variations in HLA-DQ are associated with systematic physical property changes and occurrence of IDDM. Members of the Swedish Childhood Diabetes Study.

Sanjeevi CB, Lybrand TP, DeWeese C, Landin-Olsson M, Kockum I, Dahlquist G, Sundkvist G, Stenger D, Lernmark A.

Diabetes. 1995 Jan;44(1):125-31.

130.

Pathogenesis of insulin-dependent diabetes mellitus.

Falorni A, Kockum I, Sanjeevi CB, Lernmark A.

Baillieres Clin Endocrinol Metab. 1995 Jan;9(1):25-46. Review.

131.

Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus.

Sanjeevi CB, Lybrand TP, Landin-Olsson M, Kockum I, Dahlquist G, Hagopian WA, Palmer JP, Lernmark A.

Tissue Antigens. 1994 Aug;44(2):110-9.

132.

Islet cell autoimmunity.

Lernmark A, Möller C, Kockum I, Sanjeevi C.

J Intern Med. 1993 Oct;234(4):361-9. Review. No abstract available.

133.

Analysis of HLA-DQA1 and -DQB1 genes in Mexican Americans with insulin-dependent diabetes mellitus.

Sanjeevi CB, Zeidler A, Shaw S, Rotter J, Nepom GT, Costin G, Raffel L, Eastman S, Kockum I, Wassmuth R, et al.

Tissue Antigens. 1993 Aug;42(2):72-7.

134.

No association or linkage with HLA-DR or -DQ genes in south Indians with pulmonary tuberculosis.

Sanjeevi CB, Narayanan PR, Prabakar R, Charles N, Thomas BE, Balasubramaniam R, Olerup O.

Tuber Lung Dis. 1992 Oct;73(5):280-4.

135.

Restriction fragment length polymorphism analysis of HLA-DRB, -DQA, and -DQB genes in south Indians and Swedish Caucasians.

Sanjeevi CB, Olerup O.

Transplant Proc. 1992 Oct;24(5):1687-8. No abstract available.

136.
137.

Fetal response to maternal ascariasis as evidenced by anti ascaris lumbricoides IgM antibodies in the cord blood.

Sanjeevi CB, Vivekanandan S, Narayanan PR.

Acta Paediatr Scand. 1991 Dec;80(12):1134-8.

138.

Antifilarial and anti PPD IgM antibodies in cord blood.

Sanjeevi CB, Narayanan PR.

Indian J Pediatr. 1989 Mar-Apr;56(2):207-11.

139.

Solitary cyst of kidney in a geriatric patient presenting with haematuria.

Natrajan VS, Sanjeevi CB.

J Assoc Physicians India. 1988 Jun;36(6):387-8. No abstract available.

140.

Wolfram syndrome with limited joint mobility.

Seshiah V, Sanjeevi CB, Venkataraman S, Rao KV.

J Assoc Physicians India. 1987 Jul;35(7):528-9. No abstract available.

141.

Hand syndromes in diabetes mellitus.

Seshiah V, Sanjeevi CB.

J Assoc Physicians India. 1987 Jul;35(7):520-2. Review. No abstract available.

142.

Diabetic lower cranial polyneuropathy.

Seshiah V, Venkatraman S, Harinarayanan CV, Sanjeevi CB.

J Assoc Physicians India. 1987 May;35(5):395-6. No abstract available.

143.

Pattern of proteinuria in NIDDM--one year follow up.

Seshiah V, Venkataraman S, Hariharan RS, Sanjeevi CB, Seshasayanam M, Sarada B.

J Med Assoc Thai. 1987 Mar;70 Suppl 2:163-7. No abstract available.

144.

Comparison of ELISA & tube agglutination for the detection of anti Yersinia enterocolitica antibodies among arthritis patients.

Radha M, Sanjeevi CB, Narayanan PR, Chandrasekaran AN.

Indian J Pathol Microbiol. 1986 Jan;29(1):9-14. No abstract available.